CME OnDemand: New Advances in Sports and Forefoot/MIS - What's New and What's Next?
Image For Activity Cover
Expires on 05/31/2024
Member: $175.00
Non-Member: $225.00
Credit Offered
10 CME (MD) OnDemand Credits
10 CME (PA/NP/RN) OnDemand Credits
10 CEU (AT) OnDemand Credits
10 CE (PT) OnDemand Credits
10 CME (DPM) OnDemand Credits
10 CME (Other) OnDemand Credits
  • Course Details: New Advances in Sports and Forefoot/MIS - What's New and What's Next?
  • CME Overview
  • Accreditation Statement

New Advances in Sports and Forefoot/MIS - What's New and What's Next? 
Mark L. Hagy, MD, and Tyler A. Gonzalez, MD, MBA

Expand your knowledge and earn credit on your schedule with the new AOFAS OnDemand Course, New Advances in Sports and Forefoot/MIS - What's New and What's Next? 

The course consists of two modules that you can complete at any time. Each module includes five sessions led by leaders in foot and ankle orthopaedic surgery. Faculty from each module will be available within course discussion boards to answer questions and cases for one month following the launch of their module. Attendees are encouraged to interact with faculty and each other via Q&A or course chat.


 The price below includes access to the full course (both modules) through May 31, 2024. 

  • AOFAS Members: $175

  • Non-AOFAS Members $225

  • Orthopaedic Residents or Fellows and Medical Students: $40 (Use discount code: RESFELLOW2023)

Nonmember medical students, residents and fellows must fax program verification to 847-692-3315 prior to registering. 

Forefoot Module

The forefoot module focuses on minimally invasive surgical (MIS) procedures/techniques and the MIS options for treating these complex issues.

Learning Objectives

At the conclusion of this module, you will be able to:

  • Understand common problems in the forefoot

  • Understand new minimally invasive surgical techniques in forefoot surgery

  • Present advanced treatment methodologies in the forefoot


MIS Lesser Toes
Jonathan R.M. Kaplan, MD

What's New in Hallux Valgus Surgery
Oliver N. Schipper, MD

Hallux Rigidus: Evolution of Minimally Invasive Techniques
Amiethab A. Aiyer, MD

Hallux Varus: What's New in Management
Edward T. Haupt, MD

Update on Turf Toe and Plantar Plate Pathology
M. Truitt Cooper, MD

Sports Module

Faculty available to answer questions May 1 - May 31, 2023.

The sports module focuses on the most up-to-date methods to diagnose and treat athletes and ways to advance rehabilitation in common athletic injuries. Additionally, the module will discuss minimally invasive options for common problems in athletes, such as insertional Achilles tendinopathy and Achilles tendon tears.

Learning Objectives

At the conclusion of this module, you will be able to:

  • Understand the most up-to-date treatment algorithms for common sports injuries

  • Obtain new perspectives and ways to return athletes to play after various foot and ankle surgeries

  • Gain current literature-based knowledge to advance your diagnostic and treatment skill


Lisfranc Complex Injuries
Anny C. Hsu, MD

Evaluation and Treatment of Syndesmotic Injuries
J. Benjamin Jackson III, MD, MBA

MIS Percutaneous Zadek Osteotomy for Insertional Achilles Tendinopathy
Tyler A. Gonzalez, MD, MBA

Lateral Ankle Instability
Jess H. Mullens, MD

Achilles Tendon Tears
Kenneth W. DeFontes III, MD

Statement of Need

A need for this educational activity has been determined based on previous course evaluations and the AOFAS educational curriculum. The content of this course was based on current issues and topics provided by AOFAS membership and leadership. For more information on the AOFAS CME mission, visit


The American Orthopaedic Foot & Ankle Society (AOFAS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Learn more about the AOFAS CME Program Mission 



AOFAS requires all instructors, planners, and other individuals in a position to control or influence the content of an educational activity to disclose all relevant financial relationships or affiliations during the past 12 months with any commercial interest (any entity producing, marketing, re-selling, or distributing healthcare goods and services consumed by, or used on patients). All identified conflicts of interest must be resolved and the education content vetted by AOFAS for fair balance, scientific objectivity, and appropriateness. AOFAS also requires faculty to disclose when off-label/unapproved uses of a product are discussed in a CME activity. AOFAS attests that the persons responsible for the development of this educational activity did so independently and were not influenced by commercial supporters. All financial disclosures will be provided to meeting attendees in the final program materials.


The material presented in this continuing medical education activity has been made available by the American Orthopaedic Foot & Ankle Society (AOFAS) for educational purposes only. This material is not intended to represent the only, nor necessarily the best, methods or procedures appropriate for the medical situation discussed, but rather is intended to present an approach, view, statement, or opinion of the authors or presenters, which may be helpful or of interest to other practitioners. Methods, techniques, and procedures demonstrated and views and opinions expressed by speakers, presenters, and faculty are their own, and do not necessarily represent those of AOFAS, nor does presentation on the program represent or constitute endorsement or promotion by AOFAS. AOFAS expressly disclaims any warranties or guarantees, expressed or implied, and shall not be liable for damages of any kind in connection with the material, methods, information, techniques, opinions, or procedures expressed, presented, or demonstrated.

FDA Statement
Some drugs or medical devices demonstrated at this meeting have not been cleared by the FDA or have been cleared by the FDA for specific purposes only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or medical devices he or she wishes to use in clinical practice. AOFAS policy provides that “off label” uses of a drug or medical device may be described in its CME activities so long as the “off label” use of the drug or medical device is also specifically disclosed (i.e., it must be disclosed that the FDA has not cleared the drug or device for the described purpose). Any drug or medical device is being used “off label” if the described use is not set forth on the products approval label.

Faculty/Planner Disclosure Declaration
As an Accreditation Council for Continuing Medical Education (ACCME) provider, AOFAS has the obligation to ensure the delivery of education that is balanced and free of commercial bias. To achieve this, it is the policy of the AOFAS that all CME-related board members, committee members (“planners”), faculty, and appropriate staff disclose in writing to the learners’ all financial relationships that you have had in the past 24 months with ineligible companies. An “ineligible company” are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

In addition to faculty members, commentators from the floor are charged with verbally disclosing any interests immediately prior to speaking. All disclosures are provided in this final program distributed at the meeting to all program participants.

In accordance with AOFAS policy:
Faculty participation in this educational activity will be predicated upon timely submission and review of AOFAS disclosure. An individual who refuses to disclose all financial relationships will be disqualified from being a planning committee member, a teacher, or an author of CME, and cannot have control of, or responsibility for, the development, management, presentation, or evaluation of the CME activity. Non-compliance will result in a faculty member being stricken from the program.

An indication of the participant’s disclosure appears after his or her name as well as the ineligible company that provided the support. AOFAS does not view the existence of these disclosed interests or commitments as necessarily implying bias or decreasing the value of the author’s participation in this activity. In addition to ensuring that presentations be free of bias, faculty members are required to ensure that all material presented and discussed will be based on best- available evidence.


The American Orthopaedic Foot & Ankle Society (AOFAS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AOFAS designates this enduring activity for a maximum of 10 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Each module is worth 5 CME Credits, and all credits may be claimed at the conclusion of the full course. 

American Orthopaedic Foot & Ankle Society®
Orthopaedic Foot & Ankle Foundation
9400 W. Higgins Road, Suite 220, Rosemont, IL 60018
800-235-4855 or +1-847-698-4654 (outside US)
Copyright© 2021 All Rights Reserved
Powered By